Kairos Pharma Ltd. (KAPA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.73
-0.04 (-2.26%)
At close: Jan 17, 2025, 3:59 PM
1.73
0.00%
After-hours Jan 17, 2025, 06:30 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Net Income | -1.81M | -1.05M | -2.15M | -1.05M |
Depreciation & Amortization | 160.00K | 160.00K | 98.00K | n/a |
Stock-Based Compensation | 913.00K | n/a | 300.00K | 800.00K |
Other Working Capital | 764.00K | 129.00K | 1.19M | 212.82K |
Other Non-Cash Items | 56.00K | 408.00K | 144.00K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | 764.00K | 129.00K | 1.19M | 212.82K |
Operating Cash Flow | 81.00K | -353.00K | -412.00K | -38.53K |
Capital Expenditures | n/a | n/a | n/a | n/a |
Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -109.00K | n/a |
Investing Cash Flow | n/a | n/a | -109.00K | n/a |
Debt Repayment | n/a | 895.00K | 330.00K | 50.00K |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -425.00K | -178.00K | n/a | -13.00K |
Financial Cash Flow | -425.00K | 717.00K | 580.00K | 37.00K |
Net Cash Flow | -344.00K | 364.00K | 59.00K | -1.53K |
Free Cash Flow | 81.00K | -353.00K | -412.00K | -38.53K |